These sports innovation companies have joined Pokatok. Photo via Getty Images

A Houston-based organization focused on advancing sports tech startups has named its latest cohort.

Pokatok Labs announced the addition of six companies to its portfolio as the program — focused on seed and series A startups across health tech, gaming, fan experience, and more — kicks off. Lasting nine weeks and held twice a year, Pokatok's inaugural cohort was announced in May. Participating companies receive access to a network of organizations, advisors, investors, and subject matter experts within sports tech.

"We are pumped to launch our second cohort of all-star companies. If it's possible, this collection of startups may be even more outstanding than the last group," says Lawson Gow, Pokatok's co-founder. "We are eager to immerse them into the Texas market and to otherwise support their growth in any way that we can."

Gow, founder of The Cannon, launched the program with Chris Buckner, founder of Mainline, and Alex Gras, former chief commercial officer of The Cannon. (Note: Lawson Gow is the son of David Gow, the CEO of InnovationMap's parent company, Gow Media.)

The fall 2022 cohort for Pokatok includes:

Adapt Brands

Image via adaptbrands.com

California-based Adapt Brands is a superfood company that's creating Hemp-infused products as natural alternatives to synthetic beverages, supplements, and opioids. The company is founded by CEO Richard Harrington.

AGOGIE

Image via agogie.com

AGOGIE — based in St. Louis, Missouri, and founded by CEO Aaron Mottern — designs apparel with resistance bands built inside, creating a new category of apparel that burns calories and fat, activates and strengthens muscle, and is suitable for all day wear.

Fabric

Photo via fabric.space

Los Angeles-based Fabric brings fandom to the metaverse with its a geospatial web platform that enables sports teams to create and launch a Space, an interactive and social 3D jumbotron.

Ongo

Image via ongo.com

Ongo, headquartered in San Francisco, is a subscription-based software company designing solutions for users to approach health and wellness.

Recut

Image via Unsplash

New York-based Recut provides tools for users to personalized video content at scale.

Tallysight

Image via tallysight.com

Tallysight, founded in San Diego by CEO Matt Peterson, is an all-in-one creator monetization platform for individuals and businesses in digital sports media and betting.


Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

This Houston suburb named one of 10 newest boomtowns in U.S.

Booming 'Burb

What do you get when you combine a city's surge in population, housing growth, and economy? For the Houston suburb of Conroe, it adds up to being America's No. 9 newest boomtown, according to a new survey from SmartAsset.

The personal finance website's just-released report analyzed more than 400 U.S. cities with populations of 65,000 or more to identify places experiencing rapid growth based on five-year changes in economic output, housing units, and labor force size.

Texas is home to the second-highest concentration of new boomtowns in America with 18 out of 75 located in the Lone Star State. Only Florida ranks higher than Texas by just one.

However, Texas nearly locked out the top five most bustling boomtowns in America. Austin suburb Georgetown topped the list, and its Central Texas neighbors New Braunfels (No. 2) and Leander (No. 4) ranked close behind. Dallas-Fort Worth mid-city Lewisville claimed the No. 5 spot. Lehi, Utah ranked in third place.

Conroe has soared in popularity as one of America's most sought-after suburbs over the last several years, boosted by its renter-friendliness and its livability among the millennial generation.

Conroe has seen a 37 percent increase in housing units from 2019 to 2024, with its labor force growing by 33 percent during that time. SmartAsset also determined that Montgomery County's economic output grew at compound annual rates of 4.9 percent.

The report says population booms and "expanding business activity" can create "visible momentum" for an up-and-coming city, but these fast changes can alter a city in ways residents may not expect.

"In recent years, some American cities stand out for attracting people, investment and development at a pace that sets them apart," the report said. "Boomtown status does not mean growth benefits everyone equally, but it does reflect a city’s expanding economic capacity and the new opportunities that come with it."

America's top 10 new boomtowns are:

  • No. 1 – Georgetown
  • No. 2 – New Braunfels
  • No. 3 – Lehi, Utah
  • No. 4 – Leander
  • No. 5 – Lewisville
  • No. 6 – Palm Coast, Florida
  • No. 7 – Nampa, Idaho
  • No. 8 – McKinney
  • No. 9 – Conroe
  • No. 10 – Frisco
---

This article originally appeared on CultureMap.com.

Houston brain health co. secures $6.5M for rare disease study

neuro funding

Houston-based Goldenrod Therapeutics, part of Fannin Partners' portfolio, has announced the initial close of a $6.5 million series seed preferred stock round.

The round was led by Ataxia Ventures and an affiliate of Fannin, according to a news release.

Goldenrod Therapeutics plans to use the funding to support manufacturing, formulation optimization, IND-enabling studies and a Phase I study of its drug to treat brain inflammation, known as 11h.

The study will consider how 11h, which blocks the enzyme PDE4, could treat Friedreich’s ataxia (FA), a rare genetic disease that affects movement, speech and balance. To date, other PDE4 inhibitors have proven to regulate neuroinflammation and neuronal signaling, but have had adverse gastrointestinal side effects or have not reached enough of the central nervous system, according to Goldenrod.

The company says its 11h is expected to have "broad applicability" with limited emetric side effects.

“Our 11h program is a next-generation, orally bioavailable, brain-penetrant PDE4 inhibitor, where researchers overcame longstanding limitations associated with earlier PDE4 inhibitors," Dr. Dev Chatterjee, CEO of Goldenrod, said in the news release. "We believe this creates the potential for a best-in-class therapy for Friedreich’s Ataxia and a potential foundation for development across multiple neurodegenerative and neuroinflammatory disorders.”

11h was first developed at the University of Nebraska Medical Center (UNeMed). Houston-based Fannin Partners in-licensed the product 2020 and landed SBIR Phase I funding to support its initial development for opioid use disorder soon after.

Goldenrod has also received funding to study 11h's effectiveness for multiple sclerosis, methamphetamine addiction and cocaine addiction.

Goldenrod says it is developing 11h to target a variety of neurological and inflammatory conditions, including Alzheimer's disease, multiple sclerosis, ALS, substance use disorders, Batten disease, pain and traumatic brain injury.